{"filing":{"accession_number":"0001193125-26-261670","cik":"0001991792","ticker":"CGON","company_name":"CG Oncology, Inc.","form":"8-K","filing_date":"2026-06-08","report_date":null,"primary_document":"d54487d8k.htm","primary_document_url":"https://www.sec.gov/Archives/edgar/data/1991792/000119312526261670/d54487d8k.htm"},"events":[{"id":6190,"run_id":5436,"accession_number":"0001193125-26-261670","anchor_item_number":"5.07","event_type":"shareholder_vote_results","event_domain":"governance","is_material":true,"confidence":0.98,"summary":"This 8-K Item 5.07 discloses the final voting results from CG Oncology's June 4, 2026 Annual Meeting of Stockholders, including four proposals: election of two Class II directors (Christina Rossi and Victor Tong, Jr.), ratification of Ernst \u0026 Young LLP as independent auditor, advisory approval of named executive officer compensation, and advisory vote on compensation vote frequency. The disclosure presents detailed vote tallies for each matter, which is the core content of Item 5.07 shareholder vote results.","company_name":"CG Oncology, Inc.","ticker":"CGON","filing_date":"2026-06-08","form":"8-K","submitted_at":null,"items":[{"id":5153,"accession_number":"0001193125-26-261670","item_number":"5.07","item_title":"Submission of Matters to a Vote of Security Holders.","event_type":"shareholder_vote_results","event_domain":"governance","is_material":true,"confidence":0.98,"reasoning":"This 8-K Item 5.07 discloses the final voting results from CG Oncology's June 4, 2026 Annual Meeting of Stockholders, including four proposals: election of two Class II directors (Christina Rossi and Victor Tong, Jr.), ratification of Ernst \u0026 Young LLP as independent auditor, advisory approval of named executive officer compensation, and advisory vote on compensation vote frequency. The disclosure presents detailed vote tallies for each matter, which is the core content of Item 5.07 shareholder vote results.","classifier_version":"claude-haiku-4-5-20251001+prompt-9e0ffca5","taxonomy_version":"v1","classified_at":"2026-06-08T20:04:17.735120+00:00","company_name":"","ticker":null,"filing_date":""}]}],"classifications":[{"id":5153,"accession_number":"0001193125-26-261670","item_number":"5.07","item_title":"Submission of Matters to a Vote of Security Holders.","event_type":"shareholder_vote_results","event_domain":"governance","is_material":true,"confidence":0.98,"reasoning":"This 8-K Item 5.07 discloses the final voting results from CG Oncology's June 4, 2026 Annual Meeting of Stockholders, including four proposals: election of two Class II directors (Christina Rossi and Victor Tong, Jr.), ratification of Ernst \u0026 Young LLP as independent auditor, advisory approval of named executive officer compensation, and advisory vote on compensation vote frequency. The disclosure presents detailed vote tallies for each matter, which is the core content of Item 5.07 shareholder vote results.","classifier_version":"claude-haiku-4-5-20251001+prompt-9e0ffca5","taxonomy_version":"v1","classified_at":"2026-06-08T20:04:17.735120+00:00","company_name":"CG Oncology, Inc.","ticker":"CGON","filing_date":"2026-06-08"}]}